Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer

J Spicer; T Plunkett; N Somaiah; S Chan; A Kendall; N Bolunwu; H Pandha

doi:10.1038/sj.pcan.4500821

Back

$Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer$

Journal article

Peer reviewed

Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer

J Spicer, T Plunkett, N Somaiah, S Chan, A Kendall, N Bolunwu and H Pandha

PROSTATE CANCER AND PROSTATIC DISEASES, Vol.8(4), pp.364-368

01/12/2005

DOI: https://doi.org/10.1038/sj.pcan.4500821

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

Urology & Nephrology

ONCOLOGY

UROLOGY & NEPHROLOGY

capecitabine

chemotherapy

PSA

FLUOROURACIL PLUS LEUCOVORIN

METASTATIC COLORECTAL-CANCER

INTRAVENOUS FLUOROURACIL

BREAST-CANCER

FOLINIC ACID

5-FLUOROURACIL

TRIAL

MITOXANTRONE

THERAPY

PREDNISONE

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000234418000012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

33 Record Views

8 Times Cited - Web of Science

See more details

Details

Title: Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer
Creators: J Spicer
T Plunkett
N Somaiah
S Chan
A Kendall
N Bolunwu
H Pandha
Publication Details: PROSTATE CANCER AND PROSTATIC DISEASES, Vol.8(4), pp.364-368
Publisher: NATURE PUBLISHING GROUP
Date published: 01/12/2005
Date submitted: 17/05/2017
Identifiers: 99514033902346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer

Abstract

Files and links (1)

Metrics

Details

Usage Policy